Experimental hypercupremia does not result in increases in copper in lens, iris, or ocular fluids

Area of Science:

• Ocular toxicology
• Trace element metabolism
• Pharmacokinetics

Background:

• Copper is an essential trace element vital for various physiological processes.
• Understanding copper distribution is crucial for assessing potential ocular toxicity.
• The blood-ocular barrier limits the passage of substances into the eye.

Purpose of the Study:

• To investigate the ocular distribution of systemically administered copper sulfate in rabbits.
• To determine if excess absorbed copper crosses the blood-ocular barrier.

Main Methods:

• Rabbits received continuous subcutaneous administration of copper sulfate via osmotic pumps.
• Plasma, liver, and ocular tissues/fluids were collected after one month.
• Copper concentrations were quantified using atomic absorption spectrophotometry.

Main Results:

• Dose-dependent increases in plasma and liver copper levels were observed, confirming systemic absorption.
• No significant elevation in copper content was detected in ocular fluids, lens, or iris.
• Results indicate the blood-ocular barrier effectively restricts copper entry into the eye.

Conclusions:

• Systemically absorbed copper does not accumulate in ocular tissues in rabbits.
• The protein-bound nature of copper in circulation likely prevents its passage across the blood-ocular barrier.
• This suggests a low risk of ocular toxicity from systemically absorbed excess copper.